Nonalcoholic Fatty Liver Disease Subtypes Exhibit Distinctive Cardiovascular Risk Profiles
An international team of researchers has discovered the existence of three subtypes of...
Read MorePosted by Andy Lundin | Mar 23, 2022 | Diabetes & Metabolic Diseases |
An international team of researchers has discovered the existence of three subtypes of...
Read MorePosted by Chris Wolski | Oct 22, 2021 | Diabetes & Metabolic Diseases |
New research creates a road map for future treatments of nonalcoholic fatty liver disease and confirms the need for more mainstream screening.
Read MorePosted by Chris Wolski | Jun 17, 2021 | Diabetes & Metabolic Diseases |
Researchers have identified a noninvasive biomarker that can identify patients at risk of NAFLD complications using a simple blood test.
Read MorePosted by Laurie Bonner | Mar 26, 2021 | Disease States |
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read MorePosted by Laurie Bonner | Sep 29, 2020 | Diabetes & Metabolic Diseases, Hematology & Serology |
LabCorp will develop and commercialize a blood-based molecular diagnostic test powered by NIS4 technology to help identify patients with at-risk nonalcoholic steatohepatitis.
Read More